Request for Covid-19 Impact Assessment of this Report
The United States Small Molecule Targeted Cancer Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Small Molecule Targeted Cancer Therapy market, reaching US$ million by the year 2028. As for the Europe Small Molecule Targeted Cancer Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Small Molecule Targeted Cancer Therapy players cover OncoGenex Pharmaceuticals, Inc., Cytokinetics Inc., Hospira Inc., and GlaxoSmithKline plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Targeted Cancer Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Other Cancers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule Targeted Cancer Therapy Market Size 2017-2028
2.1.2 Small Molecule Targeted Cancer Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Small Molecule Targeted Cancer Therapy Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecules
2.2.3 Small Molecule Drug Conjugates
2.3 Small Molecule Targeted Cancer Therapy Market Size by Type
2.3.1 Small Molecule Targeted Cancer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2022)
2.4 Small Molecule Targeted Cancer Therapy Segment by Application
2.4.1 Lymphoma
2.4.2 Melanoma
2.4.3 Multiple Myeloma
2.4.4 Breast Cancer
2.4.5 Prostate Cancer
2.4.6 Other Cancers
2.5 Small Molecule Targeted Cancer Therapy Market Size by Application
2.5.1 Small Molecule Targeted Cancer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2022)
3 Small Molecule Targeted Cancer Therapy Market Size by Player
3.1 Small Molecule Targeted Cancer Therapy Market Size Market Share by Players
3.1.1 Global Small Molecule Targeted Cancer Therapy Revenue by Players (2020-2022)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Small Molecule Targeted Cancer Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule Targeted Cancer Therapy by Regions
4.1 Small Molecule Targeted Cancer Therapy Market Size by Regions (2017-2022)
4.2 Americas Small Molecule Targeted Cancer Therapy Market Size Growth (2017-2022)
4.3 APAC Small Molecule Targeted Cancer Therapy Market Size Growth (2017-2022)
4.4 Europe Small Molecule Targeted Cancer Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
5.2 Americas Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
5.3 Americas Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Targeted Cancer Therapy Market Size by Region (2017-2022)
6.2 APAC Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
6.3 APAC Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy by Country (2017-2022)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Targeted Cancer Therapy by Region (2017-2022)
8.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Small Molecule Targeted Cancer Therapy Market Forecast
10.1 Global Small Molecule Targeted Cancer Therapy Forecast by Regions (2023-2028)
10.1.1 Global Small Molecule Targeted Cancer Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Small Molecule Targeted Cancer Therapy Forecast
10.1.3 APAC Small Molecule Targeted Cancer Therapy Forecast
10.1.4 Europe Small Molecule Targeted Cancer Therapy Forecast
10.1.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Forecast
10.2 Americas Small Molecule Targeted Cancer Therapy Forecast by Country (2023-2028)
10.2.1 United States Small Molecule Targeted Cancer Therapy Market Forecast
10.2.2 Canada Small Molecule Targeted Cancer Therapy Market Forecast
10.2.3 Mexico Small Molecule Targeted Cancer Therapy Market Forecast
10.2.4 Brazil Small Molecule Targeted Cancer Therapy Market Forecast
10.3 APAC Small Molecule Targeted Cancer Therapy Forecast by Region (2023-2028)
10.3.1 China Small Molecule Targeted Cancer Therapy Market Forecast
10.3.2 Japan Small Molecule Targeted Cancer Therapy Market Forecast
10.3.3 Korea Small Molecule Targeted Cancer Therapy Market Forecast
10.3.4 Southeast Asia Small Molecule Targeted Cancer Therapy Market Forecast
10.3.5 India Small Molecule Targeted Cancer Therapy Market Forecast
10.3.6 Australia Small Molecule Targeted Cancer Therapy Market Forecast
10.4 Europe Small Molecule Targeted Cancer Therapy Forecast by Country (2023-2028)
10.4.1 Germany Small Molecule Targeted Cancer Therapy Market Forecast
10.4.2 France Small Molecule Targeted Cancer Therapy Market Forecast
10.4.3 UK Small Molecule Targeted Cancer Therapy Market Forecast
10.4.4 Italy Small Molecule Targeted Cancer Therapy Market Forecast
10.4.5 Russia Small Molecule Targeted Cancer Therapy Market Forecast
10.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Small Molecule Targeted Cancer Therapy Market Forecast
10.5.2 South Africa Small Molecule Targeted Cancer Therapy Market Forecast
10.5.3 Israel Small Molecule Targeted Cancer Therapy Market Forecast
10.5.4 Turkey Small Molecule Targeted Cancer Therapy Market Forecast
10.5.5 GCC Countries Small Molecule Targeted Cancer Therapy Market Forecast
10.6 Global Small Molecule Targeted Cancer Therapy Forecast by Type (2023-2028)
10.7 Global Small Molecule Targeted Cancer Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 OncoGenex Pharmaceuticals, Inc.
11.1.1 OncoGenex Pharmaceuticals, Inc. Company Information
11.1.2 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product Offered
11.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 OncoGenex Pharmaceuticals, Inc. Main Business Overview
11.1.5 OncoGenex Pharmaceuticals, Inc. Latest Developments
11.2 Cytokinetics Inc.
11.2.1 Cytokinetics Inc. Company Information
11.2.2 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product Offered
11.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cytokinetics Inc. Main Business Overview
11.2.5 Cytokinetics Inc. Latest Developments
11.3 Hospira Inc.
11.3.1 Hospira Inc. Company Information
11.3.2 Hospira Inc. Small Molecule Targeted Cancer Therapy Product Offered
11.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hospira Inc. Main Business Overview
11.3.5 Hospira Inc. Latest Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Information
11.4.2 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product Offered
11.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 GlaxoSmithKline plc Main Business Overview
11.4.5 GlaxoSmithKline plc Latest Developments
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Information
11.5.2 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product Offered
11.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Boehringer Ingelheim GmbH Main Business Overview
11.5.5 Boehringer Ingelheim GmbH Latest Developments
11.6 Bayer HealthCare AG
11.6.1 Bayer HealthCare AG Company Information
11.6.2 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product Offered
11.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bayer HealthCare AG Main Business Overview
11.6.5 Bayer HealthCare AG Latest Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Small Molecule Targeted Cancer Therapy Product Offered
11.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbott Laboratories Main Business Overview
11.7.5 Abbott Laboratories Latest Developments
12 Research Findings and Conclusion
Table 1. Small Molecule Targeted Cancer Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Small Molecules
Table 4. Major Players of Small Molecule Drug Conjugates
Table 5. Small Molecule Targeted Cancer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2022)
Table 8. Small Molecule Targeted Cancer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2022)
Table 11. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Player (2020-2022)
Table 13. Small Molecule Targeted Cancer Therapy Key Players Head office and Products Offered
Table 14. Small Molecule Targeted Cancer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Small Molecule Targeted Cancer Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Regions (2017-2022)
Table 19. Americas Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Small Molecule Targeted Cancer Therapy Market Size Market Share by Country (2017-2022)
Table 21. Americas Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2022)
Table 23. Americas Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2022)
Table 25. APAC Small Molecule Targeted Cancer Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Small Molecule Targeted Cancer Therapy Market Size Market Share by Region (2017-2022)
Table 27. APAC Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2022)
Table 29. APAC Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2022)
Table 31. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Country (2017-2022)
Table 33. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2022)
Table 35. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Small Molecule Targeted Cancer Therapy
Table 44. Key Market Challenges & Risks of Small Molecule Targeted Cancer Therapy
Table 45. Key Industry Trends of Small Molecule Targeted Cancer Therapy
Table 46. Global Small Molecule Targeted Cancer Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Small Molecule Targeted Cancer Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Small Molecule Targeted Cancer Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Small Molecule Targeted Cancer Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Small Molecule Targeted Cancer Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Small Molecule Targeted Cancer Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 52. OncoGenex Pharmaceuticals, Inc. Details, Company Type, Small Molecule Targeted Cancer Therapy Area Served and Its Competitors
Table 53. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product Offered
Table 54. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. OncoGenex Pharmaceuticals, Inc. Main Business
Table 56. OncoGenex Pharmaceuticals, Inc. Latest Developments
Table 57. Cytokinetics Inc. Details, Company Type, Small Molecule Targeted Cancer Therapy Area Served and Its Competitors
Table 58. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product Offered
Table 59. Cytokinetics Inc. Main Business
Table 60. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Cytokinetics Inc. Latest Developments
Table 62. Hospira Inc. Details, Company Type, Small Molecule Targeted Cancer Therapy Area Served and Its Competitors
Table 63. Hospira Inc. Small Molecule Targeted Cancer Therapy Product Offered
Table 64. Hospira Inc. Main Business
Table 65. Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Hospira Inc. Latest Developments
Table 67. GlaxoSmithKline plc Details, Company Type, Small Molecule Targeted Cancer Therapy Area Served and Its Competitors
Table 68. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product Offered
Table 69. GlaxoSmithKline plc Main Business
Table 70. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. GlaxoSmithKline plc Latest Developments
Table 72. Boehringer Ingelheim GmbH Details, Company Type, Small Molecule Targeted Cancer Therapy Area Served and Its Competitors
Table 73. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product Offered
Table 74. Boehringer Ingelheim GmbH Main Business
Table 75. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Boehringer Ingelheim GmbH Latest Developments
Table 77. Bayer HealthCare AG Details, Company Type, Small Molecule Targeted Cancer Therapy Area Served and Its Competitors
Table 78. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product Offered
Table 79. Bayer HealthCare AG Main Business
Table 80. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Bayer HealthCare AG Latest Developments
Table 82. Abbott Laboratories Details, Company Type, Small Molecule Targeted Cancer Therapy Area Served and Its Competitors
Table 83. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product Offered
Table 84. Abbott Laboratories Main Business
Table 85. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Abbott Laboratories Latest Developments
List of Figures
Figure 1. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Type in 2021
Figure 7. Small Molecule Targeted Cancer Therapy in Lymphoma
Figure 8. Global Small Molecule Targeted Cancer Therapy Market: Lymphoma (2017-2022) & ($ Millions)
Figure 9. Small Molecule Targeted Cancer Therapy in Melanoma
Figure 10. Global Small Molecule Targeted Cancer Therapy Market: Melanoma (2017-2022) & ($ Millions)
Figure 11. Small Molecule Targeted Cancer Therapy in Multiple Myeloma
Figure 12. Global Small Molecule Targeted Cancer Therapy Market: Multiple Myeloma (2017-2022) & ($ Millions)
Figure 13. Small Molecule Targeted Cancer Therapy in Breast Cancer
Figure 14. Global Small Molecule Targeted Cancer Therapy Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 15. Small Molecule Targeted Cancer Therapy in Prostate Cancer
Figure 16. Global Small Molecule Targeted Cancer Therapy Market: Prostate Cancer (2017-2022) & ($ Millions)
Figure 17. Small Molecule Targeted Cancer Therapy in Other Cancers
Figure 18. Global Small Molecule Targeted Cancer Therapy Market: Other Cancers (2017-2022) & ($ Millions)
Figure 19. Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Application in 2021
Figure 20. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Player in 2021
Figure 21. Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Small Molecule Targeted Cancer Therapy Market Size 2017-2022 ($ Millions)
Figure 23. APAC Small Molecule Targeted Cancer Therapy Market Size 2017-2022 ($ Millions)
Figure 24. Europe Small Molecule Targeted Cancer Therapy Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size 2017-2022 ($ Millions)
Figure 26. Americas Small Molecule Targeted Cancer Therapy Value Market Share by Country in 2021
Figure 27. Americas Small Molecule Targeted Cancer Therapy Consumption Market Share by Type in 2021
Figure 28. Americas Small Molecule Targeted Cancer Therapy Market Size Market Share by Application in 2021
Figure 29. United States Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Small Molecule Targeted Cancer Therapy Market Size Market Share by Region in 2021
Figure 34. APAC Small Molecule Targeted Cancer Therapy Market Size Market Share by Application in 2021
Figure 35. China Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Country in 2021
Figure 42. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Type in 2021
Figure 43. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Application in 2021
Figure 44. Germany Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Application in 2021
Figure 52. Egypt Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Small Molecule Targeted Cancer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 58. APAC Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 59. Europe Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 61. United States Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Canada Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 65. China Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 66. Japan Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 67. Korea Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 69. India Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Australia Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Germany Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 72. France Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 73. UK Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Italy Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 75. Russia Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 76. Spain Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 79. Israel Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Small Molecule Targeted Cancer Therapy Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...